Use case – Patient Matching for Clinical Trials

  • One of the world's premier biopharmaceutical companies, Pfizer

How can you secure biomedical data processing of sensitive personal information across multiple parties?

Biomedical data processing typically requires the secure stepwise transfer of sensitive personal information across multiple parties. Pfizer used Bitmark to implement complicated multiparty interactions associated with medical data exchange.

Contact us
with Questions and for Pricing.

(Abstract from Pfizer paper) Biomedical data processing typically requires the secure stepwise transfer of sensitive personal information across multiple parties. In an effort to explore alternatives without supplemental peer-to-peer communications, the Bitmark property rights blockchain was used to design and simulate the process of assessing the suitability of individuals to enroll in specific clinical trials.

The trial matching simulation demonstrated that property rights blockchains can implement complicated multiparty interactions, such as those associated with medical data exchange.

Creating a self-coordinated marketplace for trial matching, or any other health exchange scenario, using a blockchain is highly compelling. The Bitmark blockchain and the digital property rights model in general, provided the necessary features to design, and readily simulate, blockchain-based health data exchange marketplaces. Additionally, patients, individually or via their brokers, would be able to present themselves for trial candidacy to further enrich the candidate population. More profoundly, it is demonstrable of the potential of blockchains to serve as the foundations of open marketplaces comprised of stakeholders having diverse roles engaged in complicated procedural interactions.

Leave a comment

Leave a Reply